8.21
Schlusskurs vom Vortag:
$8.39
Offen:
$8.45
24-Stunden-Volumen:
946.59K
Relative Volume:
0.75
Marktkapitalisierung:
$441.94M
Einnahmen:
$217.25M
Nettoeinkommen (Verlust:
$-50.92M
KGV:
-8.21
EPS:
-1
Netto-Cashflow:
$-100.85M
1W Leistung:
-0.36%
1M Leistung:
+18.30%
6M Leistung:
-45.48%
1J Leistung:
-60.72%
Prothena Corporation Plc Stock (PRTA) Company Profile
Firmenname
Prothena Corporation Plc
Sektor
Branche
Telefon
011-353-1-236-2500
Adresse
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Vergleichen Sie PRTA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
PRTA
Prothena Corporation Plc
|
8.21 | 445.17M | 217.25M | -50.92M | -100.85M | -1.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-28 | Herabstufung | BofA Securities | Neutral → Underperform |
2025-05-27 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
2025-05-27 | Herabstufung | Jefferies | Buy → Hold |
2025-05-27 | Herabstufung | Oppenheimer | Outperform → Perform |
2024-12-20 | Eingeleitet | Chardan Capital Markets | Buy |
2024-01-30 | Herabstufung | BofA Securities | Buy → Neutral |
2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
2023-04-24 | Eingeleitet | SVB Securities | Outperform |
2023-01-27 | Eingeleitet | Piper Sandler | Overweight |
2022-11-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2022-09-28 | Hochstufung | BofA Securities | Neutral → Buy |
2021-11-19 | Eingeleitet | JMP Securities | Mkt Outperform |
2021-06-18 | Hochstufung | BofA Securities | Underperform → Neutral |
2021-06-08 | Bestätigt | Oppenheimer | Outperform |
2021-05-26 | Eingeleitet | Citigroup | Buy |
2021-02-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2021-02-12 | Hochstufung | Jefferies | Hold → Buy |
2021-02-02 | Hochstufung | BTIG Research | Neutral → Buy |
2020-12-07 | Eingeleitet | H.C. Wainwright | Buy |
2020-07-09 | Hochstufung | Oppenheimer | Perform → Outperform |
2019-11-19 | Hochstufung | Evercore ISI | In-line → Outperform |
2018-05-21 | Herabstufung | Barclays | Equal Weight → Underweight |
2018-04-23 | Herabstufung | Jefferies | Buy → Hold |
2018-04-05 | Bestätigt | Barclays | Overweight |
2017-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
2017-09-29 | Bestätigt | BTIG Research | Buy |
2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
2017-07-11 | Eingeleitet | Jefferies | Buy |
2017-04-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
2017-04-12 | Eingeleitet | Piper Jaffray | Overweight |
2017-03-02 | Eingeleitet | Instinet | Buy |
2016-12-21 | Eingeleitet | SunTrust | Buy |
2016-11-03 | Eingeleitet | Deutsche Bank | Buy |
2016-08-04 | Bestätigt | Barclays | Overweight |
2016-05-13 | Eingeleitet | Barclays | Overweight |
2016-02-19 | Bestätigt | Wedbush | Outperform |
2016-01-21 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Prothena Corporation Plc Aktie (PRTA) Neueste Nachrichten
Will Prothena Corporation plc outperform its industry peersJuly 2025 Macro Moves & Weekly Setup with ROI Potential - khodrobank.com
Will Prothena Corporation plc price bounce be sustainable2025 Top Gainers & Daily Chart Pattern Signal Reports - Newser
Can Prothena Corporation plc lead its sector in growthJuly 2025 Levels & Free Technical Pattern Based Buy Signals - khodrobank.com
Prothena (PRTA) Up 17.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Applying Wyckoff theory to Prothena Corporation plc stockQuarterly Portfolio Review & Proven Capital Preservation Methods - Newser
Published on: 2025-09-03 09:24:25 - Newser
What to do if you’re stuck in Prothena Corporation plcMarket Performance Recap & Low Drawdown Investment Ideas - Newser
What high frequency data says about Prothena Corporation plcEntry Point & AI Powered Market Entry Ideas - Newser
Best data tools to analyze Prothena Corporation plc stockJuly 2025 Momentum & Community Consensus Picks - Newser
Screener Results Flag Prothena Corporation plc as Oversold2025 Historical Comparison & Weekly Hot Stock Watchlists - beatles.ru
How do insiders feel about Prothena Corporation plcJuly 2025 Technicals & Free Weekly Watchlist of Top Performers - khodrobank.com
Is Prothena Corporation plc a turnaround storyJuly 2025 Snapshot & Free Safe Entry Trade Signal Reports - khodrobank.com
Chart overlay techniques for tracking Prothena Corporation plcWeekly Risk Summary & Weekly Market Pulse Alerts - Newser
How institutional ownership impacts Prothena Corporation plc stockJuly 2025 Chart Watch & Free Reliable Trade Execution Plans - Newser
Is Prothena Corporation plc showing insider buyingBear Alert & Reliable Entry Point Trade Alerts - khodrobank.com
Can Prothena Corporation plc benefit from deglobalizationJuly 2025 Breakouts & Verified Swing Trading Watchlists - khodrobank.com
Is Prothena Corporation plc exposed to political riskWeekly Trade Recap & Daily Technical Stock Forecast Reports - khodrobank.com
Can swing trading help recover from Prothena Corporation plc lossesPortfolio Update Summary & Stepwise Entry/Exit Trade Alerts - Newser
Tick level data insight on Prothena Corporation plc volatilityJuly 2025 News Drivers & Entry and Exit Point Strategies - Newser
Prothena Corporation plc stock outlook for YEARMarket Performance Summary & Precise Swing Trade Alerts - Newser
Prothena Corporation plc Chart Enters High Volatility ZoneVolume Spike & Weekly Breakout Opportunity Watchlist - beatles.ru
Can technical indicators confirm Prothena Corporation plc’s reversalIPO Watch & Free Weekly Chart Analysis and Trade Guides - Newser
Relative strength of Prothena Corporation plc in sector analysisQuarterly Investment Review & Safe Entry Momentum Tips - Newser
Multi factor analysis applied to Prothena Corporation plcQuarterly Investment Review & Low Risk Investment Opportunities - Newser
Will a bounce in Prothena Corporation plc offer an exitJuly 2025 Volume & AI Driven Stock Reports - Newser
Live Scanner Shows Breakout on Prothena Corporation plcPortfolio Gains Report & Fast Gain Stock Tips - beatles.ru
Prothena Corporation plc Breaks Losing Streak — Is the Trend Reversing getLinesFromResByArray error: size == 0 - kangso.co.kr
Using data models to predict Prothena Corporation plc stock movementWeekly Risk Summary & Daily Oversold Stock Bounce Ideas - Newser
Is Prothena Corporation plc still worth holding after the dipSwing Trade & Weekly Top Performers Watchlists - Newser
Ranking Prothena Corporation plc among high performing stocks via toolsWeekly Risk Report & Target Return Focused Picks - Newser
FDA Tightens Safety Guidelines For Biogen Leqembi Alzheimer's Therapy - Benzinga
Earnings visualization tools for Prothena Corporation plcJuly 2025 Sector Moves & Weekly Chart Analysis and Trade Guides - Newser
Prothena to Participate in the Cantor Fitzgerald Global Healthcare Conference - Business Wire
Prothena Reports Non-Competitive Brain Swelling Rates In Early Alzheimer's Study - Benzinga
Piper Sandler slashes Prothena stock price target to $15 from $81 on PRX012 data By Investing.com - Investing.com South Africa
How to build a dashboard for Prothena Corporation plc stockWeekly Risk Summary & High Yield Equity Trading Tips - Newser
Finanzdaten der Prothena Corporation Plc-Aktie (PRTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Prothena Corporation Plc-Aktie (PRTA) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
EcoR1 Capital, LLC | 10% Owner |
May 06 '25 |
Sale |
7.64 |
1,984,053 |
15,164,712 |
5,304,596 |
EcoR1 Capital, LLC | 10% Owner |
May 05 '25 |
Sale |
8.11 |
977,693 |
7,930,166 |
7,288,649 |
SCULLY WILLIAM P | 10% Owner |
Jan 14 '25 |
Buy |
12.79 |
100,000 |
1,279,040 |
735,993 |
SCULLY WILLIAM P | 10% Owner |
Dec 18 '24 |
Buy |
13.93 |
73,436 |
1,022,670 |
1,297,693 |
SCULLY WILLIAM P | 10% Owner |
Dec 31 '24 |
Buy |
13.01 |
32,000 |
416,393 |
650,193 |
SCULLY WILLIAM P | 10% Owner |
Dec 20 '24 |
Buy |
15.91 |
2,000 |
31,813 |
618,693 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):